Last quarter (Q4 2023), AbCellera Biologics's total revenue was $12.36M, a decrease of -42.63% from the same quarter last year. In Q4, AbCellera Biologics's net income was $-47.15M. See AbCellera Biologics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 18.99M	$ 44.80M	$ 485.42K	$ 375.20M	$ 233.16M	$ 11.61M
Cost of Revenue	-	-	-	$ 45.52M	$ 27.14M	$ 0.00
Gross Profit	$ 18.99M	$ 44.80M	$ 485.42K	$ 329.69M	$ 206.01M	$ 11.61M
Operating Expense	$ 136.86M	$ 275.23M	$ 268.91K	$ 107.79M	$ 41.66M	$ 13.96M
Operating Income	$ -117.87M	$ -230.43M	$ 216.51K	$ 221.90M	$ 164.35M	$ -2.34M
Net Non Operating Interest Income Expense	$ 21.73M	$ 42.25M	$ 12.03K	$ -1.90M	$ -6.22M	$ -54.00K
Other Income Expense	$ -8.18M	$ -14.15M	$ -10.55K	$ -855.00K	$ -300.00K	$ 186.00K
Pretax Income	$ -87.96M	$ -174.03M	$ 239.10K	$ 219.15M	$ 157.83M	$ -2.21M
Tax Provision	$ -12.13M	$ -27.63M	$ 80.58K	$ 65.69M	$ 38.91M	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -75.83M	$ -146.40M	$ 158.52K	$ 153.46M	$ 85.10M	$ -2.21M
Basic EPS	$ -0.51	$ -0.51	$ 0.56	$ 0.56	$ 0.53	$ -0.01
Diluted EPS	$ -0.51	$ -0.51	$ 0.50	$ 0.48	$ 0.45	$ -0.01
Basic Average Shares	$ 1.16B	$ 289.17M	$ 285.06M	$ 275.76M	$ 159.20M	$ 172.38M
Diluted Average Shares	$ 1.16B	$ 289.17M	$ 314.83M	$ 318.29M	$ 263.13M	$ 172.38M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 136.86M	$ 275.23M	$ 268.91K	$ 153.30M	$ 68.80M	$ 13.96M
Net Income From Continuing And Discontinued Operation	$ -75.83M	$ -146.40M	$ 158.52K	$ 153.46M	$ 118.92M	$ -2.21M
Normalized Income	$ -100.10M	$ -201.66M	$ 175.74K	$ 154.06M	$ 119.14M	$ -2.40M
Interest Expense	-	-	-	$ 5.22M	$ 6.51M	$ 209.00K
EBIT	$ -87.96M	$ -174.03M	$ 239.10K	$ 224.37M	$ 164.34M	$ -2.00M
EBITDA	$ -71.43M	$ -143.13M	$ 272.20K	$ 241.62M	$ 169.62M	$ -155.00K

Currency in USD

AbCellera Biologics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing